Clinical Trials on Hyperoxalurie, primär

Total 7996 results

Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
Baxalta now part of Shire

Completed

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
Assaf-Harofeh Medical Center

Unknown

Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis (MRMF01)

Myelofibrosis, Primary | Myelofibrosis, Post PV | Myelofibrosis, Post ET

Israel
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Computer Modelling of the Cervical Spine Movements in Cervical Dystonia (STICOB)

Cervical Dystonia, Primary

France
OcuTherix, Inc.

Terminated

Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Primary Open-angle Glaucoma (POAG) | Ocular Hypertension (OHT)

Philippines
Inotek Pharmaceuticals Corporation

Completed

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma (MATrX-1)

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
Fresenius Kabi

Completed

Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder Surgery

Enteral Nutrition Regimen Prior to Surgery

United Kingdom
University of Zurich

Recruiting

Identification of New Inborn Errors of Immunity

Primary Immune Deficiency Disorder

Switzerland
National Institute of Allergy and Infectious Diseases...

Recruiting

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Primary Immune Deficiency

United States, Turkey
Octapharma

Completed

Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

Primary Immune Deficiency Disorder

United States
Happyr Ltd
The Leeds Teaching Hospitals NHS Trust

Withdrawn

Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine

Primary Headache Disorder

United Kingdom
University Hospital, Caen

Completed

Pediatric Intensive Care Unit and Primary Immune Deficiency (PICUPID)

Immuno-Deficiency

France
West China Hospital

Completed

Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy

Primary Liver Cancer

China
Apollomics (Australia) Pty. Ltd.
Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...

Completed

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Solid Tumor | Microsatellite Instability | Mismatch Repair Deficiency | Cancer of Unknown Primary Site

Australia
Octapharma

Completed

Study of Octanorm Subcutaneous IG in Patients With PID

Primary Immune Deficiency Disorder

United States, Canada, Czechia, Hungary, Poland, Russian Federation, Slovakia
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Pain | Carcinoma of Unknown Primary

United States
Ottawa Hospital Research Institute
Octapharma

Unknown

Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment

Primary Immunodeficiency Disease | Secondary Immunodeficiency

Canada
University of Eastern Piedmont
University of Milan

Completed

Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects

Hyperparathyroidism | Hypercalcemia

Italy
Hadassah Medical Organization

Unknown

Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.

Primary Brain Tumor

Israel
Instituto Grifols, S.A.

Completed

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

Primary Immune Deficiency Disease

United States
Imagine Institute
Assistance Publique - Hôpitaux de Paris; Saint Antoine University Hospital

Completed

Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease (DIPobiota)

Primary Immune Deficiencies

France
The First Hospital of Hebei Medical University

Not yet recruiting

HUTT to Assess Cardiac Autonomic Nervous Function

Autonomic Nervous System Diseases
Tulane University
Saul's Light Foundation

Recruiting

The Effect of Reading Therapy on Newborns

Autonomic Nervous System Diseases

United States
University Hospital, Montpellier

Terminated

Effects of NMES on Muscle Function of Patients With FSHD: a Double-blind Randomized Controled Clinical Trial (NEMS and FSHD)

Primary Disease Facioscapulohumeral Dystrophy (FSHD)

France
Fausto Medeiros Mendes

Completed

Endodontic Treatment of Necrotic Primary Teeth With Guedes Pinto Paste: A Randomized Clinical Trial

Endodontic Treatment of Primary Teeth

Brazil
Istanbul University

Completed

Comparison of The Success Rates of Four Different Pulpotomy Techniques

Extensive Decay in Primary Molars
Smith & Nephew Orthopaedics AG

Completed

Multicenter Clinical Observation PROMOS®

Primary and Secondary Omarthrosis
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A

GnRH Antagonist | Preimplantation Genetic Testing | Progestin-primed Ovarian Stimulation | Euploid Rate

China
University Hospital, Montpellier

Recruiting

Routine Health Care of Patients With FSHD (FSHD)

Primary Disease Fascioscapulohumeral Dystrophy (FSHD)

France
University Medical Center Groningen

Enrolling by invitation

Effects of Communication Training to Involve Older People in Decisions to DEPRESCRIBE Cardiometabolic Medication: a Cluster-randomized Trial in Primary Care (CO-DEPRESCRIBE)

Primary Health Care | Polypharmacy | Deprescriptions | Community Pharmacy Services | Decision Making, Shared

Netherlands
University Ghent

Completed

Biodentine Versus White MTA Pulpotomy

Extensive Decay in Primary Molars

Belgium
NORCE Norwegian Research Centre AS
Norwegian Labour and Welfare Administration

Completed

Effect Evaluation of Independent Medical Evaluation (IME) in Norway (NIME)

All International Classification of Primary Care 2 Diagnoses

Norway
Kecioren Education and Training Hospital

Completed

Sympathetic-parasympathetic Ratio of Our Gaze

Autonomic Nervous System Diseases

Turkey
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Primary HIV Prevention in Pregnant and Lactating Ugandan Women (PRIMAL)

Primary Prevention of HIV Acquisition

Uganda
Pontificia Universidad Catolica de Chile
Fundacion MAPFRE; Fundacion Hispanoamericana de Solidaridad

Completed

Family Preventive Visits to Detect Risk Factors in the Family

Preventive Medicine | Family | Family Practice | Adolescent Health Services | Primary Heath Care

Chile
ABM Therapeutics Shanghai Company Limited

Recruiting

A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors

Primary Malignant Brain Tumor

China
University of Zurich

Recruiting

Pathophysiology of Inborn Immunodeficiencies

Primary Immune Deficiency Disorder

Switzerland
Children's Hospital of Philadelphia
University of California, San Francisco

Recruiting

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Immunodeficiencies | Immune Dysregulation Syndromes

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Antibody Production in Immune Disorders

Primary Immune Deficiency

United States
Green Cross Corporation

Withdrawn

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Primary Immune Deficiency Disorder
Kuwait Society for Allergy and Clinical Immunology

Completed

Primary Immunodeficiency in Kuwait

Primary Immune Deficiency Disorder

Kuwait
Amgen

Completed

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Hyperparathyroidism, Primary | Hypercalcemia

United States, Canada, Russian Federation, Hungary, Australia, Portugal, Poland
Odense University Hospital

Completed

Evaluation of Preoperative Investigations in Patients With Liver Cancer

Primary Liver Cancer | Liver Metastasis

Denmark
Karolinska University Hospital

Completed

Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency (VITAPID)

Primary Immune Deficiency Disorder

Sweden
Roswell Park Cancer Institute

Completed

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism | Parathyroid Gland Adenoma

United States
Octapharma

Completed

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

Primary Immune Deficiency Disorder

Russian Federation
CSL Behring

Completed

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Primary Immune Deficiency Disorder

Japan
Mansoura University

Completed

Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy

Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy
Curis, Inc.

Recruiting

A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma

Relapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System Lymphoma

United States, Spain, France, Czechia, Israel, Italy, Poland

Clinical Trials on Hyperoxalurie, primär

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations